Add Yahoo as a preferred source to see more of our stories on Google. One way or another, beta blockers are always in the news. Take, for instance, Los Angeles Chargers Head Coach Jim Harbaugh, who ...

Short-term withdrawal of beta-blockers improved exercise outcomes in certain patients with heart failure with preserved ejection fraction (HFpEF), according to a small randomized trial. After 2 weeks ...

Add Yahoo as a preferred source to see more of our stories on Google. Illustration: Cat O'Neil/The Guardian (Illustration: Cat O'Neil/The Guardian) I first took beta blockers two years ago, when I was ...

Credit: Getty Images A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD. Beta blockers have long been included in the ...

Beta blockers have long been widely prescribed for patients with heart issues, but two new studies this week question the benefit of the therapies in certain patients with strong heart function. One ...

Please provide your email address to receive an email when new articles are posted on . Beta-blocker use at hospital admission for acute decompensated HF was associated with lower in-hospital ...

Beta blockers have been shown to prolong survival in chronic heart failure. It is currently a matter of debate whether any β blocker is superior to the other in terms of improving symptoms, left ...

CDC: Prescription Opioid Use Stable Since 2006 A case study in Pharmacotherapy describes a patient with metoprolol overdose who developed cardiac arrest and worsening progression after numerous ...

Please provide your email address to receive an email when new articles are posted on . Patients who used a beta-blocker with Simbrinza had significantly delayed allergy onset, which may boost ...

Share on Pinterest Experts say beta-blockers are essential medications for a number of heart-related conditions. Shikhar Bhattarai/Stocksy Beta-blockers are used to treat heart problems and high blood ...

There was no increased fall risk established in patients using selective beta-blockers (HR 0.92, 95% CI 0.83, 1.01). Factors such as lipid solubility and enzyme activity were also determined to not ...